Aurora Spine Corporation
TSX VENTURE : ASG

Aurora Spine Corporation

July 02, 2014 08:00 ET

Aurora Spine Announces First Surgery Using TiNano™ Interbody Cage

CARLSBAD, CALIFORNIA--(Marketwired - July 2, 2014) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the first surgery using the Discovery™ interbody cage with TiNano™ plasma spray coating. The surgery, a multi-level case, was performed at Tri-City Medical Center in Oceanside, CA by Dr. Neville Alleyne.

"The new TiNano titanium spray blast coating has increased the surface area for superior osteointegration. TiNano is the next generation of interbody fusion cages" said Dr. Alleyne. Dr. Alleyne is a board-certified orthopedic surgeon and the director of the Orthopaedic Spine Center at Tri-City Medical Center. He uses minimally invasive approaches to spinal disorders.

The Aurora Discovery cages with TiNano plasma spray coating allow for bone ingrowth due to its porous structure. The surgery marks the introduction of the TiNano product line, the most recent addition of advanced spinal products in the Aurora MIS portfolio. Aurora Spine continues to expand its product offerings in support of its mission of minimally invasive technology.

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of Aurora Spine's products in surgical procedures. Aurora Spine cautions investors of its securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

Contact Information

  • Aurora Spine Corporation
    Trent Northcutt
    President and Chief Executive Officer
    (760) 424-2004

    Eric Fronk
    Chief Financial Officer
    (760) 424-2004